Pharmos Corporation (PARS) Reports Second Quarter 2012 Results
7/31/2012 10:13:54 AM
More...
|
Pharmos Corporation (PARS) Announces Successful Completion of Proof-of-concept Clinical Trial of Levotofisopam for the Treatment of Gout
5/18/2012 11:06:25 AM
More...
|
Pharmos Corporation (PARS) Reports First Quarter 2012 Results
4/16/2012 10:30:46 AM
More...
|
Pharmos Corporation (PARS) Provides Update on Ongoing Clinical Trial of Levotofisopam for the Treatment of Gout
4/6/2012 9:58:35 AM
More...
|
Pharmos Corporation (PARS) Reports 2011 Fourth Quarter and Full Year Results
2/21/2012 9:44:08 AM
More...
|
Pharmos Corporation (PARS) Announces Dosing of First Patients in Clinical Trial of Levotofisopam for the Treatment of Gout
1/11/2012 10:21:28 AM
More...
|
Pharmos Corporation (PARS) Reports 2011 Third Quarter Results
11/1/2011 11:42:09 AM
More...
|
Pharmos Corporation (PARS) Reports 2011 Second Quarter Results
8/9/2011 11:26:01 AM
More...
|
Pharmos Corporation (PARS) Reports First Quarter 2011 Results
4/28/2011 4:54:50 PM
More...
|
Pharmos Corporation (PARS) Reports Fourth Quarter and Full Year 2010 Results
2/18/2011 7:07:17 AM
More...
|
|